Adagene Inc.
NASDAQ: ADAG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Luo
- Employees
- 138
- Headquarters
- Suzhou, China
- IPO year
- 2021
- Market cap
- $160.0M
- Website
- https://www.adagene.com
Loading ADAG…
Loading profile data…Frequently asked questions about ADAG
What does Adagene Inc. (ADAG) do?
Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human tri...
Where does ADAG trade?
Adagene Inc. (ADAG) trades on the NASDAQ Global Market.
What sector is ADAG in?
Adagene Inc. (ADAG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Adagene Inc.?
Peter Luo is the chief executive officer of Adagene Inc. (ADAG).
Where is Adagene Inc. headquartered?
Adagene Inc. is headquartered in China.
Does ADAG pay a dividend?
Adagene Inc. (ADAG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADAG go public?
Adagene Inc. (ADAG) completed its initial public offering in 2021.
Is ADAG an ADR?
Yes — ADAG is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Adagene Inc. reporting and dividends follow the underlying issuer.